<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2972">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04806880</url>
  </required_header>
  <id_info>
    <org_study_id>WP-2020-06</org_study_id>
    <nct_id>NCT04806880</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application</brief_title>
  <acronym>COVIDANOSMIA</acronym>
  <official_title>Prospective Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weprom</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kelindi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre National de la Recherche Scientifique, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital of Tours</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Weprom</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anosmia is a symptom present in 40 to 80% of patients and usually only lasts 1 to 2 weeks.&#xD;
      However, in nearly one in five patients, it can last beyond or even several months with&#xD;
      consequences in terms of undernutrition and depression. However, olfactory rehabilitation is&#xD;
      a technique validated in post-infectious anosmia since 2014 and recommended by international&#xD;
      learned societies to accelerate recovery with nearly 63% improvement in anosmia In the&#xD;
      context of the health crisis linked to the coronavirus, approximately 1 million French people&#xD;
      will have persistent anosmia following an infection with COVID-19. A web-application to&#xD;
      support the olfactory coaching of anosmic patients and help with follow-up seems relevant to&#xD;
      promote recovery and the proper conduct of this coaching.&#xD;
&#xD;
      covidanosmie.fr is a web application dedicated to olfactory rehabilitation, accessible free&#xD;
      of charge.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>16 Weeks</target_duration>
  <primary_outcome>
    <measure>Evaluation of the rate of patients presenting an improvement in their anosmia</measure>
    <time_frame>16 weeks</time_frame>
    <description>Number of patients with an improvement in anosmia (increase of at least 1 point on the visual analogue scale 0-10) on the number of users</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the time until recovery of at least 1point in 10 (Visual Analog Scale) from anosmia,</measure>
    <time_frame>16 weeks</time_frame>
    <description>Time between the date of first use of the application and the date of recovery of at least one point of anosmia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of the duration of anosmia</measure>
    <time_frame>16 weeks</time_frame>
    <description>Time between the date of diagnosis or onset of anosmia and the date of final recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the recovery of at least one point in 10 (Visual Analog Scale) depending on the oils</measure>
    <time_frame>16 weeks</time_frame>
    <description>Evolution of the VAS according to the different oils, proportion of patients with an increase of at least 1 point in anosmia on a visual analog scale (from 0 no smell to 10 normal smell) of each oil</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>users</arm_group_label>
    <description>Users of web-application</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Web-application</intervention_name>
    <description>support for olfactory coaching consisting of the inhalation of fragrant essential oils.</description>
    <arm_group_label>users</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All users of the application who have not objected to the use of their data&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Post-COVID anosmia lasting more than 1 month&#xD;
&#xD;
          -  Consent to the use of data via the application&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other causes of anosmia than COVID&#xD;
&#xD;
          -  Contraindication to olfactory coaching (allergy to one of the aromatic oils)&#xD;
&#xD;
          -  Minor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice DENIS, MD</last_name>
    <role>Study Director</role>
    <affiliation>Weprom</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Magali BALAVOINE</last_name>
    <phone>241382940</phone>
    <phone_ext>0033</phone_ext>
    <email>m.balavoine@weprom.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>ILC</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice DENIS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fabrice DENIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 17, 2021</study_first_submitted>
  <study_first_submitted_qc>March 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2021</study_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Web-application</keyword>
  <keyword>Anosmia</keyword>
  <keyword>COVID-19</keyword>
  <keyword>coaching</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olfaction Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

